![Erik Deichmann Heegaard](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Erik Deichmann Heegaard
Plus aucun poste en cours
Profil
Erik Deichmann Heegaard worked as a Medical Director in Novartis Corp.
He then worked as the Chief Medical Officer-GLP 1 Project in Novo Nordisk A from 2011 to 2014.
Currently, he is working as the Chief Medical Officer in Evaxion Biotech A from 2021 to 2023.
Dr. Deichmann Heegaard completed his undergraduate and doctorate degrees from the University of Copenhagen.
Anciens postes connus de Erik Deichmann Heegaard
| Sociétés | Poste | Fin |
|---|---|---|
| EVAXION A/S | Directeur Technique/Scientifique/R&D | 01/03/2023 |
| NOVO NORDISK A/S | Directeur Technique/Scientifique/R&D | 01/01/2014 |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | Corporate Officer/Principal | - |
Formation de Erik Deichmann Heegaard
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
33
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Novo Nordisk A/S
 Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | Health Technology |
University of Copenhagen
 University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Evaxion Biotech A/S
 Evaxion Biotech A/S BiotechnologyHealth Technology Develops novel vaccines | Health Technology |
